Shanghai Serum Bio-Technology Co., Ltd.

¥31.22As of Sun 8 Nov 2026, 12:00 UTC
SSE:688163Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 0.16%
Div yield 1.22%
ROE 4.48%
Biotechnology
Beta (5Y) 0.70
PE TTM 66.46
TSR TTM 29.41%
Mkt cap ¥3.379B
ROIC 11.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥40
29.21%
(80.30%)
Hold 3|4|11|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.28
0.27
0.25
0.27
3.59%
0.10%
—
7.57%
Revenue¥M
248.1
253.8
255.7
256.5
15.97%
16.88%
12.25%
8.77%
Peers (US$506.5M)
Cap (US$)
PE
513.5M
263.7x
506.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.435
0.098
0.079
EBIT/Intx
0.938
2.882
2.806
Own earn%
(0.12)
8.50
3.08
Sh yield%
48.85
40.79
38.18
Owners
Insiders/Inst%
8.43
66.17
Short interest%
0.93
SBC / revenue%
1.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
3–7
$1 testx
0.0
Incr. ROIC%
8